Cargando…
Histone-Mutant Glioma: Molecular Mechanisms, Preclinical Models, and Implications for Therapy
Pediatric high-grade glioma (pHGG) is the leading cause of cancer death in children. Despite histologic similarities, it has recently become apparent that this disease is molecularly distinct from its adult counterpart. Specific hallmark oncogenic histone mutations within pediatric malignant gliomas...
Autores principales: | Graham, Maya S., Mellinghoff, Ingo K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582376/ https://www.ncbi.nlm.nih.gov/pubmed/33003625 http://dx.doi.org/10.3390/ijms21197193 |
Ejemplares similares
-
Leptomeningeal disease in histone-mutant gliomas
por: Diaz, Maria, et al.
Publicado: (2023) -
Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical development
por: Tsai, C T, et al.
Publicado: (2017) -
Molecular Heterogeneity in BRAF-Mutant Gliomas: Diagnostic, Prognostic, and Therapeutic Implications
por: Lhermitte, Benoit, et al.
Publicado: (2023) -
Preclinical Models of Low-Grade Gliomas
por: Dasgupta, Pushan, et al.
Publicado: (2023) -
Targeting Histone Deacetylases for Cancer Therapy: From Molecular Mechanisms to Clinical Implications
por: Li, Zhiming, et al.
Publicado: (2014)